Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Semler Scientific, Inc.

Get SEC filing alerts via email and in your feed for Semler Scientific, Inc.

SMLR

Semler Scientific, Inc.

About Semler Scientific, Inc.

Semler Scientific develops FDA-cleared vascular testing products, notably QuantaFlo, to aid in diagnosing peripheral arterial disease and other cardiovascular conditions. The company serves healthcare providers, insurance plans, and risk assessment groups, offering non-invasive, rapid blood flow assessments. It also invests in bitcoin as a treasury reserve asset, leveraging its digital assets to support long-term value and inflation hedging.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Semler Scientific, Inc.

1
1
Semler Scientific, Inc. Semler Scientific Reports 45% Revenue Decline in Q3 2025, Despite Increased Net Income Driven by Bitcoin Gains

Via official filing (AI summary) | 7 months ago | 0 comments

2
1
Semler Scientific, Inc. Semler Scientific Reports 43% Revenue Decline but Significant Net Income Increase in Latest Quarter

Via official filing (AI summary) | 11 months ago | 0 comments

3
1
Semler Scientific, Inc. Semler Scientific Reports 44% Revenue Decline and $64.7 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

4
1
Semler Scientific, Inc. Semler Scientific Reports 17% Revenue Decline, Net Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments